https://www.sigmaaldrich.com/KR/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/IL/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sanger.ac.uk/news_item/2014-03-17-sanger-institute-spinout-kymab-announces-therapeutic-antibody-discovery-technology/
Sanger Institute spinout Kymab announces therapeutic antibody discovery technology
Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced today the publication in Nature...
sanger institutetherapeutic antibodyspinoutannouncesdiscovery
https://www.sigmaaldrich.com/PL/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/preclinical-development
Therapeutic Antibody Preclinical Development
Tools to accelerate preclinical studies in antibody drug development, from toxicity to immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy.
therapeutic antibodypreclinicaldevelopment
https://www.sigmaaldrich.com/IT/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/MY/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/SG/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/preclinical-development
Therapeutic Antibody Preclinical Development
Tools to accelerate preclinical studies in antibody drug development, from toxicity to immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy.
therapeutic antibodypreclinicaldevelopment
https://www.sigmaaldrich.com/SK/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/preclinical-development
Therapeutic Antibody Preclinical Development
Tools to accelerate preclinical studies in antibody drug development, from toxicity to immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy.
therapeutic antibodypreclinicaldevelopment
https://www.yumab.com/
Yumab - Therapeutic antibody discovery and development - Yumab
therapeutic antibodyyumabdiscoverydevelopment
https://www.sigmaaldrich.com/VN/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/preclinical-development
Therapeutic Antibody Preclinical Development
Tools to accelerate preclinical studies in antibody drug development, from toxicity to immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy.
therapeutic antibodypreclinicaldevelopment
https://www.sigmaaldrich.com/BE/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/BR/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.biospace.com/medarex-inc-and-b-genpat77-b-announce-therapeutic-antibody-co-development-agreement
Medarex, Inc. And GenPat77 Announce Therapeutic Antibody Co-Development Agreement - BioSpace
therapeutic antibodyco developmentmedarexincannounce
https://www.sigmaaldrich.com/SK/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/DK/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/preclinical-development
Therapeutic Antibody Preclinical Development
Tools to accelerate preclinical studies in antibody drug development, from toxicity to immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy.
therapeutic antibodypreclinicaldevelopment
https://www.sigmaaldrich.com/IE/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/ID/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/DK/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.prnewswire.com/news-releases/cusabio-transmembrane-proteins-driving-breakthroughs-in-therapeutic-antibody-discovery-302291677.html
CUSABIO Transmembrane Proteins: Driving Breakthroughs in Therapeutic Antibody Discovery
/PRNewswire/ -- In recent years, antibody therapies have seen rapid advancements, becoming pivotal treatments for cancer, infectious diseases, and autoimmune...
transmembrane proteinstherapeutic antibodycusabiodrivingbreakthroughs
https://www.sigmaaldrich.com/JP/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/AR/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/VN/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/target-discovery
Therapeutic Antibody Target Discovery
Identify novel targets for therapeutic antibody development using the most comprehensive set of genome-wide functional genomics screening tools available.
therapeutic antibodytargetdiscovery
https://www.sigmaaldrich.com/IE/en/integrated-offerings/monoclonal-antibodies/antibody-drug-discovery/preclinical-development
Therapeutic Antibody Preclinical Development
Tools to accelerate preclinical studies in antibody drug development, from toxicity to immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy.
therapeutic antibodypreclinicaldevelopment
https://www.jax.org/jax-mice-and-services/preclinical-research-services/antibody-therapeutics
Therapeutic Antibody Services | Jackson Laboratory
JAX Therapeutic Antibody Services offers drug discovery and development using next-generation mice, with efficacy and safety testing.
therapeutic antibodyservicesjacksonlaboratory
https://www.mdpi.com/2076-393X/3/3/519
Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2...
Despite the promise of targeted therapies, there remains an urgent need for effective treatment for esophageal cancer (EC) and triple-negative breast cancer...
https://informaconnect.com/bispecifics-asia/sponsors/adc-review-journal-of-antibody-drug-conjugates/
ADC Review | Journal of Antibody-drug Conjugates | Antibody & Protein Therapeutic Discovery Asia
Organisation profile for ADC Review | Journal of Antibody-drug Conjugates
antibody drug conjugatesreview journaladc
https://informaconnect.com/bispecifics-asia/digital-experience/
Digital Experience | Antibody & Protein Therapeutic Discovery Asia
digital experienceantibodyproteintherapeuticdiscovery
https://openreview.net/forum?id=0cJ8ERfnrM&referrer=%5Bthe%20profile%20of%20Edith%20Lee%5D(%2Fprofile%3Fid%3D~Edith_Lee1)
Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design | OpenReview
Recently, there has been an increased interest in accelerating drug design with machine learning (ML). Active ML-guided design of biological sequences with...
out oftherapeutic proteinantibodydistribution
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1533407/full
Frontiers | Inhibition of EETosis with an anti-citrullinated histone antibody: a novel therapeutic...
Eosinophils are a subset of granulocytes that protect the host against fungal and parasitic infection through secretion of their granular contents. In respon...
https://www.jci.org/assets/328880/powerpoint
JCI - A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I...
https://www.rcsb.org/structure/3IU3
RCSB PDB - 3IU3: Crystal structure of the Fab fragment of therapeutic antibody Basiliximab in...
Crystal structure of the Fab fragment of therapeutic antibody Basiliximab in complex with IL-2Ra (CD25) ectodomain
https://www.epo.org/de/boards-of-appeal/decisions/t141398eu1
T 1398/14 (Detection of therapeutic antibody/HOFFMANN-LA ROCHE) vom 18.06.2019
https://elifesciences.org/articles/34375v3
Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody |...
https://elifesciences.org/articles/34375v1
Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody |...
https://www.jci.org/articles/view/20371
JCI - Therapeutic CD154 antibody for lupus: promise for the future?
jcitherapeuticcd154antibodylupus
https://www.fda.gov/science-research/licensing-and-collaboration-opportunities/therapeutic-and-prophylactic-anti-influenza-virus-neuraminidase-1-n1-antibody-cd6-novel-epitope
Therapeutic and Prophylactic Anti-Influenza Virus Neuraminidase 1 (N1) Antibody (Cd6) With a Novel...
CD6 is a potent monoclonal antibody against N1 subtypes of NA that inhibits the enzymatic activity of the NA protein, including NA variants resistant to NA...